RESUMO
We investigated the expression of insulin-like growth factor 1 (IGF-1) and IGF-1 type 1 receptor (IGF-1R) in skeletal muscle fiber types in chickens with hepatic fibrosis induced by bile duct ligation (BDL). Eleven hens, approximately 104 weeks old, were randomly assigned to BDL (n = 4) and sham surgery (SHAM; n = 7) groups. In BDL hens, histopathology revealed marked bile duct proliferation and liver fibrosis. The cross-sectional area (CSA) of myofibers from both the pectoralis (PCT) muscles significantly decreased in the BDL group compared with the SHAM group (P < 0.01). In contrast, the CSA of myofibers from the femorotibialis lateralis (FTL) muscle did not decrease in the BDL group. Type I fibers were large, round, and hypertrophic. Elongated type IIA and IIB fibers were also present. For IGF-1 immunostaining, the immunoreaction intensity was higher in the PCT in the BDL group than the SHAM group. Within the BDL group, type I fibers from FTL had a stronger immunoreaction intensity than the type II fibers. For IGF-1R immunostaining, the intensity of the immunoreactions was similar within the PCT in the BDL group compared with the SHAM group. For FTL, type I fibers had stronger reactions to IGF-1R than type II fibers in the BDL group. These results suggest that type I fibers express both IGF-1 and IGF-1R and become hypertrophic in chickens with hepatic fibrosis.
Assuntos
Galinhas , Fator de Crescimento Insulin-Like I , Animais , Feminino , Fator de Crescimento Insulin-Like I/genética , Fator de Crescimento Insulin-Like I/metabolismo , Fígado/metabolismo , Cirrose Hepática/veterinária , Fibras Musculares Esqueléticas/metabolismo , Receptor IGF Tipo 1/genética , Receptor IGF Tipo 1/metabolismoRESUMO
Bioactive peptides are released from meat proteins by enzymatic hydrolysis (i.e., gastrointestinal digestion, aging/storage, fermentation, and protease treatment). Such peptides attribute physiological functions to meat and meat products and are promising food ingredients for developing functional foods. Meat by-products (e.g., blood and collagen) are also good sources for generating bioactive peptides, since they are produced in large quantities and are rich in proteins. Although protein-derived bioactive peptides are attractive ingredients, their changes by the Maillard reaction during processing, cooking, and storage should be investigated. This article briefly reviews the production of bioactive peptides from meat and meat by-products. Such diverse peptides affects circulatory, nervous, alimentary, and immune systems. Then, the bioactivities of Maillard reaction products (MRPs) generated from protein hydrolysates are discussed. Special attention is paid to bioactivities of 2,5-dimethyl-4-hydroxy-3(2H)-furanone (DMHF) inhalation. As such activities, we have evaluated the impact of DMHF on blood pressure, moods, brainwaves, and dietary intake. Our efforts for understanding various aspects and implication of peptides and MRPs from meat proteins would open new avenues in the meat and food industry.
Assuntos
Produtos da Carne/análise , Carne/análise , Peptídeos/química , Animais , Furanos/química , Furanos/farmacologia , Hidrólise , Reação de Maillard , Proteínas de Carne/químicaAssuntos
Bloqueio Cardíaco/diagnóstico , Prednisolona/análogos & derivados , Recuperação de Função Fisiológica , Sarcoidose/diagnóstico , Tomografia Computadorizada de Emissão , Adulto , Doença Crônica , Eletrocardiografia , Fluordesoxiglucose F18 , Granuloma/patologia , Coração/diagnóstico por imagem , Bloqueio Cardíaco/etiologia , Bloqueio Cardíaco/terapia , Humanos , Linfonodos/patologia , Masculino , Radioisótopos de Nitrogênio , Valor Preditivo dos Testes , Prednisolona/uso terapêutico , Recuperação de Função Fisiológica/efeitos dos fármacos , Sarcoidose/complicações , Sarcoidose/patologia , Radioisótopos de TálioRESUMO
A 60-year-old Japanese man with late-onset familial amyloid polyneuropathy type I (FAP transthyretin Met30) showed clinical improvement following auxiliary partial orthotopic liver transplantation (APOLT) from an ABO-incompatible living related donor. Preoperatively, plasmapheresis and immunosuppressant drugs were used to reduce serum antibodies against the donor's ABO type. APOLT was chosen so the residual liver could sustain the patient in the event of hyperacute rejection. OLT is applicable to late-onset FAP transthyretin Met30, and APOLT can be considered in ABO-incompatible cases.
Assuntos
Sistema ABO de Grupos Sanguíneos , Neuropatias Amiloides Familiares/sangue , Neuropatias Amiloides Familiares/cirurgia , Incompatibilidade de Grupos Sanguíneos , Transplante de Fígado/métodos , Humanos , Imunossupressores/uso terapêutico , Doadores Vivos , Masculino , Pessoa de Meia-Idade , Plasmaferese , Cuidados Pré-OperatóriosRESUMO
BACKGROUND: Impaired myocardial flow reserve (MFR) in patients with familial hypercholesterolemia (FH) without evidence of ischemia has been reported. However, it has not been clarified whether diminished MFR in such male or female patients with FH can be reversed by simvastatin. METHODS AND RESULTS: Sixteen patients with FH and 16 age-matched control subjects were studied. All patients were proved to have no evidence of exercise stress-induced myocardial ischemia. Baseline myocardial blood flow (MBF) and MBF during dipyridamole administration (MBF [DP]) were measured with positron emission tomography and nitrogen 13 ammonia; MFR was then calculated before and 9 to 15 months after therapy with simvastatin (5-10 mg/day). Total cholesterol level was significantly higher in patients with FH (277 +/- 49.0) than in control subjects (190 +/- 14.9) but was normalized after lipid-lowering therapy (205 +/- 40.3). Baseline MBF was comparable among FH patients before (77.6 +/- 11.6 mL/min/100 g) and after therapy (74.5 +/- 9.62 mL/min/100 g) and control subjects (78.5 +/- 29.9 mL/min/100 g). However, MBF (DP) in FH patients before therapy (178 +/- 50.9 mL/min/100 g) was significantly lower than that in control subjects (282 +/- 148 mL/min/100 g) and was significantly improved after therapy (228 +/- 91.6 mL/min/100 g, P <.05). In fact, there was no statistically significant difference in the MBF (DP) value in FH patients after therapy compared with that in control subjects (P =.09). MFR significantly improved after therapy in patients with FH (3.33 +/- 1.19 vs 2.27 +/- 0.625, P <.01) and was then statistically comparable to that in control subjects (3.54 +/- 1.11). Improvement of MFR was observed whether MBF (DP) before therapy was greater than or less than 200 mL/min/100 g. MFR was improved in both male and female patients with FH. There was a significant relationship between percent change in plasma total cholesterol concentration and percent change in MFR before and after lipid-lowering therapy (r = -0.57, P <.05). CONCLUSIONS: Diminished MFR in patients with FH without evidence of ischemia can be reversed by moderate- to long-term simvastatin therapy without gender variance.
Assuntos
Anticolesterolemiantes/uso terapêutico , Circulação Coronária/efeitos dos fármacos , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Hiperlipoproteinemia Tipo II/tratamento farmacológico , Sinvastatina/uso terapêutico , Colesterol/sangue , Dipiridamol , Eletrocardiografia , Feminino , Humanos , Hiperlipoproteinemia Tipo II/sangue , Hiperlipoproteinemia Tipo II/fisiopatologia , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada de Emissão , VasodilatadoresRESUMO
UNLABELLED: Brain SPECT with 99mTc-ethylcysteinate dimer (99mTc-ECD) reveals a subacute cerebral infarct as a hypoactive area, even in the presence of postischemic hyperperfusion. The brain retention of 99mTc-ECD depends on hydrophilic conversion mediated by enzymes, and impaired enzymatic trapping is hypothesized to depress the retention efficiency in the infarcted region. The aim of this study was to determine whether the metabolic rate of 99mTc-ECD is actually reduced in infarcted brain tissue. METHODS: In 50 mmol/L phosphate buffer (pH 7.4), 99mTc-ECD was incubated for 30 min with homogenates of rat brain tissue with and without triphenyltetrazolium chloride (TTC) staining. The ratio of polar products was determined by thin-layer chromatography as a function of incubation time, and metabolic rates were obtained. Permanent focal ischemia was induced by occlusion of the right middle cerebral artery (MCA) in rats. The brain was removed 24 h after MCA occlusion, and the infarcted area was defined by TTC staining. The metabolic rate of 99mTc-ECD was determined in homogenates of infarcted tissue, contralateral noninfarcted tissue, and tissue sampled from sham-operated rats. The infarct volume was measured by direct and indirect methods to assess volume expansion caused by edema, and the metabolic rate in infarcted tissue was corrected for the effect of edema. RESULTS: TTC staining had no effect on the metabolic rate of 99mTc-ECD. The metabolic rates in the infarcted tissue were 0.222%/min +/- 0.054%/min and 0.285%/min +/- 0.064%/min before and after correction for edema, respectively. These rates were significantly lower than those in the contralateral noninfarcted tissue (0.426%/min +/- 0.028%/min) and the tissue sampled from the sham-operated rats (0.439%/min +/- 0.031%/min). No substantial difference in rates was observed between the contralateral tissue and the tissue from the sham-operated rats. CONCLUSION: The results of this study showed that infarction decreases the activity of enzymes that mediate the hydrophilic conversion of 99mTc-ECD in the brain and suggest that reduced metabolic activity is related to decreased accumulation of 99mTc-ECD in hyperperfused infarcts.
Assuntos
Encéfalo/metabolismo , Infarto Cerebral/diagnóstico por imagem , Infarto Cerebral/metabolismo , Cisteína/metabolismo , Compostos de Organotecnécio/metabolismo , Compostos Radiofarmacêuticos/metabolismo , Animais , Corantes , Cisteína/análogos & derivados , Masculino , Cintilografia , Ratos , Ratos Wistar , Sais de TetrazólioAssuntos
Antígenos de Diferenciação/genética , Sobrevivência de Enxerto/fisiologia , Transplante de Coração/imunologia , Imunoconjugados , Imunossupressores , Transplante Heterólogo/fisiologia , Transplante Homólogo/fisiologia , Abatacepte , Adenoviridae , Animais , Antígenos CD , Antígenos de Diferenciação/imunologia , Antígeno CTLA-4 , Cricetinae , Técnicas de Transferência de Genes , Terapia Genética , Vetores Genéticos , Transplante de Coração/fisiologia , Humanos , Terapia de Imunossupressão/métodos , Mesocricetus , Ratos , Ratos Endogâmicos Lew , Ratos Endogâmicos , beta-Galactosidase/genéticaRESUMO
It has been demonstrated that the administration of CTLA4Ig protein can induce the suppression of allograft and xenograft rejection. The purpose of this study is to determine the effect of adenovirus-mediated gene transfer with CTLA4Ig gene on the transgene expression and suppression of alloimmune response in allogeneic cardiac transplantation of rats. Adenoviral vectors with beta galactosidase or human CTLA4Ig cDNA (Adex/LacZ, Adex/hCTLA4Ig) were constructed. These vectors were transduced to the liver of Lewis (LEW) rats by intravenous injection. Then LEW rats received heterotopic cardiac transplantation from Dark Agouti rats. Experiments were performed using both CTLA4Ig gene transduction and/or immunosuppressant FK506. The transgene expression after adenovirus-mediated transfer with CTLA4Ig cDNA lasted for several months, compared with several weeks after that in controls, which was proportional to the blood concentration of CTLA4Ig protein. By the administration of 1 x 10(9) PFU of Adex/hCTLA4Ig, the survival of cardiac grafts was significantly prolonged, compared with controls or the use of 1 x 10(8) PFU of Adex/hCTLA4Ig. In the rats with beating grafts over 100 days, the blood concentrations of CTLA4Ig were undetectable. The combination therapy using a low titer Adex/hCTLA4Ig and low-dose of FK506 was synergistically effective on this cardiac transplantation model. In conclusion, adenovirus-mediated gene transfer with CTLA4Ig gene was efficient for the prolongation of both transgene expression and allograft survival.
Assuntos
Antígenos de Diferenciação/fisiologia , Rejeição de Enxerto/prevenção & controle , Transplante de Coração/imunologia , Imunoconjugados , Imunossupressores , Abatacepte , Adenoviridae , Animais , Antígenos CD , Antígenos de Diferenciação/genética , Antígeno CTLA-4 , Escherichia coli/genética , Técnicas de Transferência de Genes , Vetores Genéticos , Humanos , Terapia de Imunossupressão/métodos , Fígado , Ratos , Ratos Endogâmicos Lew , Ratos Endogâmicos , Transplante Heterólogo/imunologia , Transplante Homólogo/imunologia , beta-Galactosidase/genéticaRESUMO
It was previously reported that inhibition of carnitine synthesis by 3-(2,2,2-trimethyl-hydrazinium) propionate (MET-88) restores left ventricular (LV) systolic and diastolic function in rats with myocardial infarction (MI). Preservation of the calcium uptake function of sarcoplasmic reticulum Ca2+-ATPase (SERCA2) is one of the possible mechanisms by which MET-88 alleviates hemodynamic dysfunction. To test this hypothesis, the effects of MET-88 on protein content of SERCA2 were evaluated using the same rat model of heart failure. Myocardial protein content of hexokinase, which is one of the key enzymes of glucose utilization, was also measured. Either MET-88 (MET-88 group) or a placebo (MI group) was administered for 20 days to rats with MI induced by coronary artery ligation. The control group underwent sham surgery (no ligation) and received placebo. In LV myocardial homogenates, the myocardial SERCA2 protein content was 32% lower (p<0.05) in the MI group than in the control group. However, in the MET-88 group myocardial SERCA2 content was the same as in the control group. Hexokinase I protein content was 29 % lower (p<0.05) in the MI group compared with the control. In contrast, hexokinase II protein content did not differ significantly among the three groups. Consequently, inhibition of carnitine synthesis ameliorates depression of SERCA2 and hexokinase I protein content which may reduce tissue damage caused by MI.
Assuntos
ATPases Transportadoras de Cálcio/metabolismo , Carnitina/antagonistas & inibidores , Hexoquinase/metabolismo , Isoenzimas/metabolismo , Infarto do Miocárdio/metabolismo , Miocárdio/enzimologia , Animais , Fármacos Cardiovasculares/farmacologia , Carnitina/biossíntese , Masculino , Metilidrazinas/farmacologia , Ratos , Ratos Sprague-Dawley , ATPases Transportadoras de Cálcio do Retículo SarcoplasmáticoRESUMO
In order to study the roles of vasoactive peptides during tissue repair of gastric ulcers, we compared concentrations in tissue surrounding gastric ulcers of endothelin-1(ET-1), adrenomedullin (AM), and transforming growth factor-beta (TGF-beta) among different stages of ulcer development. A total of 82 cases were studied. Ulcers were located in the gastric angulus in 51 cases. All cases were positive for Helicobacter pylori (Hp). Ten cases were in the active stage (GA), 18 were in the healing stage (GH), and 28 were in the scarring stage (GS). As control, 17 cases of Hp-positive gastritis (gast+) and 14 of Hp-negative gastritis (gast-) were studied. The concentrations of endothelin (ET) and TGF-beta were in the order of GH> GA> GS, and those of AM were in the order of GS > GH > GA. On immunostaining, ET stained positively in endothelial cells and vascular smooth muscle cells (VSMCs) during the GH and GS stages, and AM stained positively in histiocytes during GA, GH and GS, and also stained positively in glandular epithelia and smooth muscle fibers during GH and GS. When our results were reviewed with respect to the regulation of vascular tonus and the proliferation of VSMCs, ET and AM were considered to have roles in the regulation of proliferation.
Assuntos
Endotelina-1/análise , Mucosa Gástrica/química , Peptídeos/análise , Úlcera Gástrica/metabolismo , Fator de Crescimento Transformador beta/análise , Cicatrização , Adrenomedulina , Humanos , Técnicas ImunoenzimáticasRESUMO
We measured the concentrations of vascular endothelial growth factor (VEGF), nitric oxide and endothelin-1 (ET-1) in the gastric mucosa and examined the relationships between these factors. VEGF, nitric oxide and ET participate in angiogenesis and vascular remodeling, important elements of gastric ulcer healing. We studied cases of gastric ulcer as confirmed by endoscopic examination. All 61 cases in the angulus were positive for Helicobacter pylori (Hp). Fifteen cases were active stage (GA), 23 were healing stage (GH), and 23 were scarring stage (GS). As control, 17 cases of Hp-positive gastritis (gast+) and 14 cases of Hp-negative gastritis (gast-) were studied. Biopsy samples taken from the angulus during endoscopic examination were frozen and sliced into thin sections. ET was measured by enzyme immunoassay, VEGF was measured by enzyme-linked immunosorbent assay (ELISA) and nitric oxide was measured in terms of metabolite oxides of nitrogen (NOx) as described by Griess. ET, VEGF and inducible nitric oxide synthase (iNOS) were immunostained. The GA group had the highest concentration of NOx, suggesting that nitric oxide participates in the early stage of mucosal repair. In the GH group, all three factors showed high concentrations, suggesting that all may be involved in increased production. In the GS group, all three factors were significantly lower than in the GA and GH groups. Immunohistochemical studies showed that the distribution of ET- and iNOS-positive cells differed according to the ulcer stage. In particular, ET- and iNOS-positive cells in the vascular wall were primarily endothelial cells during GA and GH and vascular smooth muscle cells (VSMCs) during GS. These findings suggest that endothelial cells produce increased amounts of ET, nitric oxide and VEGF early in ulcer healing, a period of active endothelial cell repair and angiogenesis. During the scarring stage, vascular remodeling may result from the effects of ET and nitric oxide in regulating the proliferation of VSMCs. Our results suggest that VEGF. nitric oxide and ET participate in angiogenesis, vascular remodeling and mucosal regeneration during ulcer healing.
Assuntos
Fatores de Crescimento Endotelial/análise , Endotelinas/análise , Mucosa Gástrica/química , Linfocinas/análise , Óxido Nítrico/análise , Úlcera Gástrica/metabolismo , Cicatrização , Gastrite/metabolismo , Humanos , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Fator A de Crescimento do Endotélio Vascular , Fatores de Crescimento do Endotélio VascularAssuntos
Técnicas de Transferência de Genes , Receptores de Complemento/imunologia , Transplante Heterólogo/imunologia , Adenoviridae , Animais , Antígenos de Superfície , Complemento C3/imunologia , Células Epiteliais/imunologia , Vetores Genéticos , Cobaias , Fígado/citologia , Fígado/imunologia , Ratos , Receptores de Superfície Celular , Receptores de Complemento/genéticaRESUMO
The HLA class I and class II mediated antigen presentation plays a major role in the initiation of immune response and the development of acute rejection after transplantation. The purpose of this study was to examine whether MHC-encoded antigen processing (TAP1, TAP2, LMP2, DMA and DMB) gene polymorphisms were associated with the incidence and the severity of acute rejection after renal transplantation. We studied a selected population of 112 pairs of donors and recipients who underwent living-related renal transplantation. They were divided into 3 groups: rejection-free (Group A, n = 51), steroid-sensitive rejection (Group B, n = 31) and steroid-resistant rejection (Group C, n = 30). The frequency of TAP2*0103 (41.2%) was significantly higher in the donors of Group A than that of Group B (12.9%, p = 0.0070, pc = 0.0280) or Group C (16. 7%, p = 0.0225, pc = 0.0900). No significant difference was observed in the allelic frequencies of the TAP1, LMP2, DMA, and DMB genes in the donors or recipients among Groups A, B, and C. This result supported the idea that the TAP2 gene polymorphism might be functionally related to antigen presentation. It also suggested that donor's antigen presenting cells with the TAP2*0103 allele would have the attenuated efficacy in the presentation of allospecific antigens to recipient's T cells.
Assuntos
Transportadores de Cassetes de Ligação de ATP/genética , Apresentação de Antígeno/genética , Cisteína Endopeptidases , Rejeição de Enxerto/genética , Antígenos HLA-D/genética , Antígenos de Histocompatibilidade Classe II , Transplante de Rim/imunologia , Complexo Principal de Histocompatibilidade , Polimorfismo Genético , Proteínas/genética , Membro 2 da Subfamília B de Transportadores de Cassetes de Ligação de ATP , Membro 3 da Subfamília B de Transportadores de Cassetes de Ligação de ATP , Apresentação de Antígeno/imunologia , Rejeição de Enxerto/imunologia , Antígenos HLA-DR/genética , Cadeias HLA-DRB1 , Humanos , Estudos RetrospectivosRESUMO
We found that a short synthetic peptide corresponding to the "antisense homology box" of Fas ligand induced apoptotic cell death of Fas-expressing human ovarian cancer cell lines. The peptide was deduced from residues 256-265 of human Fas ligand, based on the hypothesis that it should contain a specific binding site to the corresponding Fas. Interestingly, the ovarian cancer cell line NOS4, which was sensitive to anti-Fas antibody induced apoptosis, was not affected by the peptide, whereas another cell line, SKOV-3, which was insensitive to anti-Fas antibody, was killed by the peptide. Thus, this short peptide was shown to have a unique activity to induce apoptosis in human ovarian cancer cells in a manner different from anti-Fas antibody.
Assuntos
Elementos Antissenso (Genética) , Apoptose , Glicoproteínas de Membrana/farmacologia , Oligopeptídeos/farmacologia , Neoplasias Ovarianas/tratamento farmacológico , Fragmentos de Peptídeos/farmacologia , Anticorpos Monoclonais/farmacologia , Anticorpos Monoclonais Murinos , Fragmentação do DNA , Proteína Ligante Fas , Feminino , Humanos , Nucleossomos , Homologia de Sequência de Aminoácidos , Células Tumorais CultivadasRESUMO
An 11-residue peptide (FQWQRNMRKVR) homologous to just over half the loop region of human lactoferricin is thought to be responsible for antimicrobial properties of human lactoferricin. Multiple antigen peptides (MAP) of the 11-residue peptide exerted significant antibacterial effects against a broad spectrum of bacteria including MRSA. More than eight branching was favourable for increasing its antibacterial activity. Our report shows a novel possibility for MAP to increase the activity of antibiotic peptides other than simply to stimulate antibody production, as reported so far.
Assuntos
Antibacterianos/farmacologia , Antígenos/farmacologia , Lactoferrina/farmacologia , Fragmentos de Peptídeos/farmacologia , Peptídeos/farmacologia , Sequência de Aminoácidos , Antibacterianos/química , Apoproteínas/química , Escherichia coli/efeitos dos fármacos , Humanos , Lactoferrina/química , Modelos Moleculares , Dados de Sequência Molecular , Fragmentos de Peptídeos/síntese química , Peptídeos/síntese química , Conformação Proteica , Estrutura Secundária de Proteína , Pseudomonas aeruginosa/efeitos dos fármacos , Salmonella/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacosAssuntos
Adenoviridae/genética , Antígenos de Diferenciação/genética , Técnicas de Transferência de Genes , Imunoconjugados , Fragmentos Fc das Imunoglobulinas/genética , Imunossupressores , Transplante de Órgãos , Proteínas Recombinantes de Fusão/genética , Abatacepte , Animais , Antígenos CD , Antígeno CTLA-4 , Transplante de Coração , Masculino , Ratos , Ratos Wistar , Transplante HeterólogoRESUMO
BACKGROUND AND PURPOSE: Dipyridamole increases the concentration of circulating adenosine, which is a potent vasodilator, by inhibition of uptake of adenosine into the erythrocytes, and hence produces coronary vasodilation. However, the effects of dipyridamole on cerebral circulation is not pronounced. This study investigates the effects of intravenous dipyridamole on cerebral blood flow (CBF) in humans with use of positron emission tomography (PET). METHODS: In each of 13 healthy subjects, CBF was measured using (15)O-labeled water and PET at rest and during hypercapnia, hypocapnia, and dipyridamole stress; corresponding CBF values were then compared. RESULTS: CBF values during dipyridamole stress were significantly lower than those measured at rest. The dipyridamole stress PaCO(2) was also significantly lower than the resting PaCO(2). The change in CBF during dipyridamole stress relative to PaCO(2) closely followed the relationship between CBF and PaCO(2) during hypocapnia. CONCLUSIONS: These results indicate that the observed decrease in CBF during dipyridamole stress was caused by a decrease in PaCO(2) rather than by any direct action of dipyridamole on CBF. The decrease in PaCO(2) during dipyridamole stress was most likely due to hyperventilation, which was a side effect of adenosine. These results support the hypothesis that circulating adenosine is largely prevented from binding to adenosine receptors of cerebral vessels by the blood-brain barrier.
Assuntos
Encéfalo/irrigação sanguínea , Circulação Cerebrovascular/efeitos dos fármacos , Dipiridamol , Tomografia Computadorizada de Emissão , Vasodilatadores , Idoso , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Gasometria , Pressão Sanguínea/efeitos dos fármacos , Encéfalo/diagnóstico por imagem , Circulação Cerebrovascular/fisiologia , Dipiridamol/administração & dosagem , Teste de Esforço/métodos , Frequência Cardíaca/efeitos dos fármacos , Humanos , Hipercapnia/sangue , Hipercapnia/diagnóstico por imagem , Hipercapnia/fisiopatologia , Hipocapnia/sangue , Hipocapnia/diagnóstico por imagem , Hipocapnia/fisiopatologia , Masculino , Pessoa de Meia-Idade , Variações Dependentes do Observador , Valores de Referência , Tomografia Computadorizada de Emissão/métodos , Vasodilatadores/administração & dosagemRESUMO
We compared the sensitivities to apoptosis via anti-Fas antibody of two human ovarian cancer cell lines, NOS4 and SKOV-3, both of which strongly express the Fas antigen on their cell surface. Treatment with anti-Fas antibody induced extensive DNA fragmentation in NOS4 cells but none in SKOV-3 cells. However; both cell lines underwent apoptosis in response to calcium ionophore A23187 or sphingomyelinase, demonstrating that the latter cell line is capable of DNA fragmentation. DNA fragmentation was not induced in either cell line by treatment with PKC activator PMA, however treatment with protein kinase C (PKC) inhibitor H-7 induced extensive DNA fragmentation in NOS4 cells, but again none in SKOV-3 cells. Protein kinase A inhibitor HA1004 treatment did not induce DNA fragmentation in either cell line. Correspondingly, treatment of cells with PMA before anti-Fas antibody or A23187 treatment partially inhibited induction of DNA fragmentation in NOS4 cells but not in SKOV-3 cells. Both NOS4 and SKOV-3 cell lines expressed isozymes of PKC at comparable levels. These results suggest the presence of a PKC-dependent anti-apoptotic mechanism in association with high sensitivity to anti-Fas antibody in these ovarian cancer cell lines.
Assuntos
Anticorpos/farmacologia , Apoptose , Neoplasias Ovarianas/metabolismo , Proteína Quinase C/metabolismo , Sulfonamidas , 1-(5-Isoquinolinasulfonil)-2-Metilpiperazina/farmacologia , Calcimicina/farmacologia , Divisão Celular/efeitos dos fármacos , Ceramidas/biossíntese , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Fragmentação do DNA/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Feminino , Citometria de Fluxo , Humanos , Isoquinolinas/farmacologia , Neoplasias Ovarianas/patologia , Proteína Quinase C/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Esfingomielina Fosfodiesterase/farmacologia , Acetato de Tetradecanoilforbol/farmacologia , Sais de Tetrazólio/metabolismo , Tiazóis/metabolismo , Células Tumorais Cultivadas , Receptor fas/biossíntese , Receptor fas/imunologiaRESUMO
Hepatic metastasis is a major factor in limiting the prognosis of patients with colon carcinoma. Recent investigations indicate a correlation between plasminogen activator profiles and hepatic metastasis. We examined the effectiveness of tissue plasminogen activator (tPA) gene therapy using a hepatic metastasis model of murine colon carcinoma. Murine colon carcinoma Colon 26 cells transduced with an MFGtPA retroviral vector (Colon 26/tPA) or an MFGLacZ retroviral vector (Colon 26/LacZ) were injected into the liver via the superior mesenteric vein of BALB/c mice, whose survival rates were checked daily. The mean survival rate of mice with hepatic metastasis induced by Colon 26/LacZ was 23.1 days, whereas that of mice with Colon 26/tPA was >100 days. The in vitro proliferation of Colon 26/tPA was comparable with that of Colon 26/LacZ, and antitumor immunity to wild-type Colon 26 cells was not induced after an intrahepatic injection of Colon 26/tPA. We suggest that transduction of the tPA gene to murine colon cancer is useful against the establishment of hepatic metastasis.